Bio-Rad Laboratories Inc (BIO)vsGE HealthCare Technologies Inc. (GEHC)
BIO
Bio-Rad Laboratories Inc
$264.49
-0.19%
HEALTHCARE · Cap: $7.14B
GEHC
GE HealthCare Technologies Inc.
$69.65
-1.04%
HEALTHCARE · Cap: $31.78B
Smart Verdict
WallStSmart Research — data-driven comparison
GE HealthCare Technologies Inc. generates 698% more annual revenue ($20.63B vs $2.58B). BIO leads profitability with a 29.4% profit margin vs 10.1%. BIO appears more attractively valued with a PEG of 1.19. GEHC earns a higher WallStSmart Score of 60/100 (C+).
BIO
Buy60
out of 100
Grade: C
GEHC
Buy60
out of 100
Grade: C+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-55.1%
Fair Value
$189.38
Current Price
$264.49
$75.11 premium
Margin of Safety
-156.0%
Fair Value
$30.94
Current Price
$69.65
$38.71 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Attractively priced relative to earnings
Reasonable price relative to book value
Safe zone — low bankruptcy risk
Keeps 29 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Every $100 of equity generates 22 in profit
Attractively priced relative to earnings
Areas to Watch
3.9% revenue growth
Weak financial health signals
Earnings declined 83.0%
Expensive relative to growth rate
Weak financial health signals
Earnings declined 17.7%
Distress zone — elevated risk
Comparative Analysis Report
WallStSmart ResearchBull Case : BIO
The strongest argument for BIO centers on P/E Ratio, Price/Book, Altman Z-Score. Profitability is solid with margins at 29.4% and operating margin at 8.9%. PEG of 1.19 suggests the stock is reasonably priced for its growth.
Bull Case : GEHC
The strongest argument for GEHC centers on Return on Equity, P/E Ratio.
Bear Case : BIO
The primary concerns for BIO are Revenue Growth, Piotroski F-Score, EPS Growth.
Bear Case : GEHC
The primary concerns for GEHC are PEG Ratio, Piotroski F-Score, EPS Growth.
Key Dynamics to Monitor
BIO carries more volatility with a beta of 1.20 — expect wider price swings.
GEHC is growing revenue faster at 7.1% — sustainability is the question.
GEHC generates stronger free cash flow (917M), providing more financial flexibility.
Monitor MEDICAL DEVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
BIO scores higher overall (60/100 vs 60/100), backed by strong 29.4% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Bio-Rad Laboratories Inc
HEALTHCARE · MEDICAL DEVICES · USA
Bio-Rad Laboratories, Inc. is an American developer and manufacturer of specialized technological products for the life science research and clinical diagnostics markets.
Visit Website →GE HealthCare Technologies Inc.
HEALTHCARE · MEDICAL DEVICES · USA
GE HealthCare Technologies Inc. provides medical technology, pharmaceutical diagnostics, and digital solutions in the United States. The company is headquartered in Chicago, Illinois.
Compare with Other MEDICAL DEVICES Stocks
Want to dig deeper into these stocks?